Healthcare startup Biofourmis closes $100 mn SoftBank Vision Fund 2-led round

Healthtech startup Biofourmis has closed a $100 mn series C funding round led by SoftBank Group Corp's Vision Fund 2, as the Japanese firm extends its bets on a sector growing through the coronavirus outbreak.

Boston-based Biofourmis uses a wearable biosensor to remotely monitor patients for changes in their health. The startup is running a programme in Singapore monitoring the condition of COVID-19 patients.